𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Angiosarcoma developing after curative induction chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the larynx

✍ Scribed by Patrick J. Gagnon; Chad Galderisi; Brandi R. Page; John M. Holland

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
233 KB
Volume
31
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

Angiosarcoma arising after radiation is described in breast cancer but occurs elsewhere. Here, we present an angiosarcoma of the neck occurring after curative chemoradiation.

Methods

This is a case of angiosarcoma developing 5 years after curative therapy for T3N0 squamous cell carcinoma of the supraglottic larynx. Therapy consisted of 3 cycles of induction cisplatin/5‐fluorouracil chemotherapy followed by radiotherapy. The patient did well until developing a rapidly progressive lesion of the left neck. Examination showed a 7‐cm mass and biopsy revealed angiosarcoma. CT scans assessed the local extent of the tumor and ruled out metastatic disease prior to initiating therapy.

Results

Therapy consisted of 4 cycles of paclitaxel chemotherapy. At completion, examination revealed mild induration of the neck with near‐complete resolution of the mass. Imaging confirmed this excellent response.

Conclusion

This rare therapy‐related second malignancy developed after curative larynx‐preserving treatment. Paclitaxel was an effective therapy in this setting. © 2008 Wiley Periodicals, Inc. Head Neck, 2009

📜 SIMILAR VOLUMES

Concurrent chemotherapy with intensity-m
Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: A retrospective single-institution analysis
✍ Nabil F. Saba; Scott Edelman; Mourad Tighiouart; Jennifer Gaultney; Lawrence W. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

## Abstract ## Background We present outcome data from concurrent chemotherapy and intensity‐modulated radiation therapy (IMRT) for squamous cell carcinoma (SCC) of the larynx and oropharyx. ## Methods Eighty patients with laryngeal (__n__ = 15) or oropharyngeal (__n__ = 65) SCC underwent concur

Cost utility of docetaxel as induction c
Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck
✍ Anju Parthan; Marshall R. Posner; Caroline Brammer; Philippe Beltran; Jeroen P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

## Abstract ## Background Trial TAX 324 showed that induction chemotherapy with docetaxel plus cisplatin and 5‐fluorouracil (TPF) compared with cisplatin and 5‐fluorouracil (PF) followed by chemoradiation increases survival and time to progression in squamous cell carcinoma of head and neck (SCCHN

Parameters that predict local control af
Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck
✍ William M. Mendenhall; Christopher G. Morris; Robert J. Amdur; Russell W. Hinerm 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB 👁 1 views

## Abstract ## Purpose. To analyze parameters that may influence the likelihood of local control after definitive radiotherapy for head and neck cancer. ## Methods. Between April 1980 and January 2000, 404 patients were treated with definitive RT alone (358 patients) or combined with adjuvant ch

Phase II study of induction chemotherapy
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck
✍ Dong M. Shin; Bonnie S. Glisson; Fadlo R. Khuri; Scott M. Lippman; Lawrence Gins 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract ## BACKGROUND This Phase II trial was conducted to determine the response rate, particularly of the primary sites, tolerability, and toxicity of induction chemotherapy of paclitaxel, ifosfamide, and carboplatin for patients with previously untreated locally advanced squamous cell carci